Quick Takeaways
- Nantahala Capital Management, LLC filed SCHEDULE 13G/A for UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY).
- Disclosed ownership: 10%.
- Date of event: 19 Dec 2024.
Nantahala Capital Management, LLC - 19 Dec 2024 SCHEDULE 13G/A Report for UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY)
- Filing Manager
- Nantahala Capital Management, LLC
- Reporting Manager
- Nantahala Capital Management, LLC
- Symbol
- UNCY
- Shares outstanding
- 108,900,320 shares
- Disclosed Ownership
- 10,879,142 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 20 Dec 2024, 16:32:24 UTC
- Date of event
- 19 Dec 2024
- Previous filing
- 14 Nov 2024
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Nantahala Capital Management, LLC disclosed 10% ownership in UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY) on 19 Dec 2024."
What Changed
- Previous schedule filing date: 14 Nov 2024.
- Current filing was accepted on 20 Dec 2024, 16:32.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 10% | 10,879,142 | 0 | 10,879,142 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer | |
| Wilmot B. Harkey | 10% | 10,879,142 | 0 | 10,879,142 | /s/ Wilmot B. Harkey | Wilmot B. Harkey / Manager | |
| Daniel Mack | 10% | 10,879,142 | 0 | 10,879,142 | /s/ Daniel Mack | Daniel Mack / Manager |